Exploring the Homeopathic Therapeutic Potential of Acorus calamus: A Multi-center Open-Label Clinical Verification Study

Abstract

Background

Clinical verification in homeopathy is a systematic process that aims to validate the therapeutic efficacy of homeopathic medicines. The Central Council for Research in Homoeopathy (CCRH) has been conducting clinical verification studies in lesser known, fragmentarily proved and rare medicines such as Acorus calamus through its Clinical Verification Program, thereby expanding the therapeutic utility of these medicines.

Objective

The primary objective of the study was to assess the change in intensity of presenting symptoms of the participants after administration of the medicine Acorus calamus by measuring change in Measure Yourself Medical Outcome Profile-2 (MYMOP-2) profile score. The study also aimed to evaluate overall impact on participants' daily living using the Outcome in Relation to Impact on Daily Living (ORIDL) scale, as well as to identify any new clinical symptoms that were not elicited during the drug proving.

Methods

A multi-center open-label study was conducted at the outpatient departments of the 14 hospitals/clinics of the CCRH located in different states of India. Participants having a minimum of three symptoms corresponding to the proving symptom of Acorus calamus were included in the study.

Results

Improvement in the symptomatology of 321 participants who completed a minimum of two follow-ups suggested the effectiveness of the medicine in treating various clinical conditions, including headache, constipation, respiratory diseases such as rhinitis, acute nasopharyngitis, sinusitis and cough, musculoskeletal disorders such as myalgia, arthralgia and cervical spondylosis, and skin conditions such as eczema. Acorus calamus showed substantial therapeutic potential, with significant improvement (p < 0.0001) in MYMOP-2 and in ORIDL scores. Symptoms that were not previously identified during the drug proving included sneezing and difficulty in breathing.

Conclusion

The study successfully verified the symptomatology of Acorus calamus by ascertaining improvement in symptoms after its administration in individuals with various health conditions. Future research can focus on randomized controlled trials to quantify the efficacy of Acorus calamus for the indicated clinical conditions.

Keywords

Acorus calamus - homeopathy - clinical verification - MYMOP-2 - ORIDL

Publikationsverlauf

Eingereicht: 29. Januar 2025

Angenommen: 30. Mai 2025

Artikel online veröffentlicht:
08. September 2025

• References

• 1 Imam H, Riaz Z, Azhar M, Sofi G, Hussain A. Sweet flag (Acorus calamus Linn.): an incredible medicinal herb. Int J Green Pharm 2013; 7: 288-296
• 2 Vermeulen F, Johnston L. Plants: Homeopathic and Medicinal Uses from a Botanical Family Perspective. Vol 3; Saltire Books; 2011
• 3 Singh S, Yadav M. A critical review of Vacha (Acorus calamus L.) in ayurvedic & modern context. World J Pharm Med Res 2022; 8: 182-187
• 4 Sharma V, Singh I, Chaudhary P. Acorus calamus (The Healing Plant): a review on its medicinal potential, micropropagation and conservation. Nat Prod Res 2014; 28: 1454-1466
• 5 Sharma V, Sharma R, Gautam DS, Kuca K, Nepovimova E, Martins N. Role of Vacha (Acorus calamus Linn.) in neurological and metabolic disorders: evidence from ethnopharmacology, phytochemistry, pharmacology and clinical study. J Clin Med 2020; 9: 1176
• 6 Jain DK, Gupta S, Jain R, Jain N. Anti-inflammatory activity of 80% ethanolic extract of Acorus calamus Linn. leaves in albino rats. Research J Pharm Tech 2010; 3: 882-884
• 7 Shah AJ, Gilani AH. Bronchodilatory effect of Acorus calamus (Linn.) is mediated through multiple pathways. J Ethnopharmacol 2010; 131: 471-477
• 8 Barua CC, Haloi P, Sen S. et al. Evaluation of gastric ulcer protective activity of Acorus calamus Linn. in laboratory animals. In: Medicinal Plants: Phytochemistry Pharmacology and Therapeutics. Daya Publishing House; 2015: 445-476
• 9 Prisilla DH, Balamurugan R, Shah HR. Antidiabetic activity of methanol extract of Acorus calamus in STZ induced diabetic rats. Asian Pac J Trop Biomed 2012; 2: 941-946
• 10 Rajput SB, Tonge MB, Karuppayil SM. An overview on traditional uses and pharmacological profile of Acorus calamus Linn. (Sweet flag) and other Acorus species. Phytomedicine 2014; 21: 268-276
• 11 German Homeopathic Pharmacopoeia. Medpharm Scientific Publishers; 2003
• 12 Subramanian P, Kumar S. Phyto-chemical standardisation of Acorus calamus L. CCRH Quarterly Bulletin 1999; 21: 15-20
• 13 Acorus calamus . CCRH Quarterly Bulletin 2004; 26: 3-12
• 14 Standardisation of Homeopathic Drugs. Vol 1. 2nd Revised Edition.. Central Council for Research in Homeopathy; 2024: 1-18
• 15 Homeopathic Drug Provings. Vol 6. Central Council for Research in Homeopathy; 14-18
• 16 Azis SP, Lata K, Vij SJ, Saini B, Kaushik S. Study of homeopathic medicines through clinical verification—a new perspective. Vol VI. Central Council for Research in Homeopathy; 2023
• 17 MYMOP. Instructions for administration and scoring. University of Bristol; . Accessed July 18, 2024 at: https://www.bristol.ac.uk/media-library/sites/primaryhealthcare/migrated/documents/adminandscoring.pdf
• 18 Reilly D, Mercer SW, Bikker AP, Harrison T. Outcome related to impact on daily living: preliminary validation of the ORIDL instrument. BMC Health Serv Res 2007; 7: 139
• 19 von Elm E, Altman DG, Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349
• 20 Hahnemann S. Organon of Medicine. 5th & 6th ed. combined.. New Delhi, India: B Jain; 2011
• 21 Daniel WW, Cross CL. Biostatistics: A Foundation for Analysis in the Health Sciences, 10^th ed. New York: John Wiley & Sons; 2013